Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 463

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort

Tagalakis, Vicky, Patenaude, Valérie, Kahn, Susan R., Suissa, Samy·2013·The American Journal of Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2013.02.024

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 37

  1. Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 · DOI · Paper page
  2. Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 · DOI · Paper page
  3. Silverstein, 1998, Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, 158, 585, 10.1001/archinte.158.6.585 · DOI · Paper page
  4. Spencer, 2006, A population-based study of the clinical epidemiology of venous thromboembolism, J Gen Intern Med, 21, 722, 10.1111/j.1525-1497.2006.00458.x · DOI · Paper page
  5. Spencer, 2009, Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study, J Thromb Thrombolysis, 28, 401, 10.1007/s11239-009-0378-3 · DOI
  6. Raskob, 2010, Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop, Am J Prev Med, 38, S502, 10.1016/j.amepre.2010.01.010 · DOI · Paper page
  7. Tagalakis, 2011, Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database, Pharmacoepidemiol Drug Saf, 20, 304, 10.1002/pds.2061 · DOI
  8. Chew, 2008, The incidence of venous thromboembolism among patients with primary lung cancer, J Thromb Haemost, 6, 601, 10.1111/j.1538-7836.2008.02908.x · DOI · Paper page
  9. Anderson, 2003, Risk factors for venous thromboembolism, Circulation, 107, I9, 10.1161/01.CIR.0000078469.07362.E6 · DOI · Paper page
  10. Oger, 2000, Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, J Thromb Haemost, 83, 657, 10.1055/s-0037-1613887 · DOI · Paper page
  11. Naess, 2007, Incidence and mortality of venous thrombosis: a population-based study, J Thromb Haemost, 5, 692, 10.1111/j.1538-7836.2007.02450.x · DOI · Paper page
  12. Tagalakis, 2012, Men had a higher risk of recurrent venous thromboembolism than women: a large population study, Gend Med, 9, 33, 10.1016/j.genm.2011.12.002 · DOI
  13. Baglin, 2004, High risk of recurrent venous thromboembolism in men, J Thromb Haemost, 2, 2152, 10.1111/j.1538-7836.2004.01050.x · DOI
  14. Rumley, 2006, Effects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60-79 years, J Thromb Haemost, 4, 982, 10.1111/j.1538-7836.2006.01889.x · DOI
  15. Previtali, 2011, Risk factors for venous and arterial thrombosis, Blood Transfus, 9, 120
  16. Yildiz, 2007, Vascular smooth muscle and endothelial functions in aging, Ann N Y Acad Sci, 1100, 353, 10.1196/annals.1395.038 · DOI
  17. 1997, Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment, Br J Surg, 84, 1099
  18. McLeod, 2001, Subcutaneous heparin versus low molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial, Ann Surg, 233, 438, 10.1097/00000658-200103000-00020 · DOI
  19. Akl, 2011, Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer, Cochrane Database Syst Rev, CD009447
  20. Agnelli, 2009, Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study, Lancet Oncol, 10, 943, 10.1016/S1470-2045(09)70232-3 · DOI · Paper page
  21. Agnelli, 2012, Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer, N Engl J Med, 366, 601, 10.1056/NEJMoa1108898 · DOI · Paper page
  22. Reiss H, Pelzer U, Deutschinoff G, et al. A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): results of the CONKO-004 trial. J Clin Oncol. 2009 ASCO Annual Meeting Proceedings. 2009;27(June 20 Suppl):LBA4506. · doi:10.1200/jco.2009.27.18_suppl.lba4506
  23. Bergqvist, 2002, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer, N Engl J Med, 346, 975, 10.1056/NEJMoa012385 · DOI · Paper page
  24. Rasmussen, 2006, Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study, J Thromb Haemost, 4, 2384, 10.1111/j.1538-7836.2006.02153.x · DOI · Paper page
  25. Heit, 1999, Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study, Arch Intern Med, 159, 445, 10.1001/archinte.159.5.445 · DOI · Paper page
  26. Kniffin, 1994, The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly, Arch Intern Med, 154, 861, 10.1001/archinte.1994.00420080053005 · doi:10.1001/archinte.1994.00420080053005 · Paper page
  27. Hansson, 1997, Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913’, Arch Intern Med, 157, 1665, 10.1001/archinte.1997.00440360079008 · DOI · Paper page
  28. Prandoni, 1996, The long-term clinical course of acute deep venous thrombosis, Ann Intern Med, 125, 1, 10.7326/0003-4819-125-1-199607010-00001 · DOI · Paper page
  29. Piccioli, 1996, Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry, Am Heart J, 132, 1010, 10.1016/S0002-8703(96)90014-9 · DOI
  30. Siddique, 1998, Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991, Am J Public Health, 88, 478, 10.2105/AJPH.88.3.478 · DOI
  31. Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 · DOI · Paper page
  32. Andresen, 2011, Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy, Thromb Res, 127, 540, 10.1016/j.thromres.2011.02.017 · DOI
  33. Sørensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504 · DOI · Paper page
  34. Levy, 1999, Coding accuracy of hospital discharge data for elderly survivals of myocardial infarction, Can J Cardiol, 15, 1277
  35. Garbe, 1998, Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma, J Clin Epidemiol, 51, 129, 10.1016/S0895-4356(97)00263-1 · DOI
  36. Firoozi, 2007, Development and validation of database indexes of asthma severity and control, Thorax, 62, 581, 10.1136/thx.2006.061572 · DOI
  37. Levy, 1995, Rates of transcervical and pertrochanteric hip fractures in the Province of Quebec, Canada, 1981-1992, Am J Epidemiol, 142, 428, 10.1093/oxfordjournals.aje.a117651 · doi:10.1093/oxfordjournals.aje.a117651

Cited by

See all 463

Metadata

Authors
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2013-09
Volume
126
Issue
9
Pages
832.e13-832.e21
ISSN
0002-9343 (ISSN-L)
OpenAlex
W1970889259
Cited by
463
References
1
FWCI
22.65
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Bayer
  • Canada Foundation for Innovation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort. https://app.cochat.ai/papers/10.1016/j.amjmed.2013.02.024
The paper
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013). Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort. The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2013.02.024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.